DISCOVERY Asia - Crestor in Type IIa and IIb hypercholesteremia

Study identifier:D3560L00009

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

: An open-label, randomised, multi-centre, phase IIIb/IV, parallel group study to compare the efficacy and safety of rosuvastatin and atorvastatin in subjects with type IIa and IIb hypercholesterolaemia (DISCOVERY)

Medical condition

Hypercholesterolemia

Phase

Phase 3

Healthy volunteers

No

Study drug

Rosuvastatin

Sex

All

Actual Enrollment

1362

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 Jun 2003
Primary Completion Date: 01 Dec 2005
Study Completion Date: 01 Feb 2007

Study design

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria